Wednesday, May 04, 2022 10:44:39 AM
Wells Fargo Sticks to Its Buy Rating for Zymeworks (ZYME)
May 04 2022 - 12:16AM
TipRanks
In a report released yesterday, Nick Abbott from Wells Fargo reiterated a Buy rating on Zymeworks (ZYME – Research Report), with a price target of $45.00. The company's shares closed last Tuesday at $7.15, close to its 52-week low of $4.56. According to TipRanks.com, Abbott has 0 stars on 0-5 stars ranking scale with an average return of -46.2% and a 0.0% success rate. Abbott covers the Healthcare sector, focusing on stocks such as TRACON Pharmaceuticals, Arcturus Therapeutics, and Alaunos Therapeutics. Currently, the analyst consensus on Zymeworks is a Strong Buy with an average price target of $23.20, which is a 256.9% upside from current levels.
https://www.tipranks.com/news/blurbs/wells-fargo-sticks-to-its-buy-rating-for-zymeworks-zyme?utm_source=advfn.com&utm_medium=referral
Recent ZYME News
- Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference • GlobeNewswire Inc. • 09/18/2024 10:00:00 AM
- Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c) • GlobeNewswire Inc. • 09/03/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:06:59 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 11:10:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/02/2024 11:00:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:18:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:13:02 PM
- Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock • GlobeNewswire Inc. • 08/01/2024 08:10:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:07:14 PM
- Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 07/30/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:35:01 PM
- Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer • GlobeNewswire Inc. • 07/25/2024 08:30:00 PM
- Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate • GlobeNewswire Inc. • 07/22/2024 10:00:38 AM
- Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 • GlobeNewswire Inc. • 07/11/2024 10:30:00 AM
- Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers • GlobeNewswire Inc. • 06/17/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:15:53 PM
- Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer • GlobeNewswire Inc. • 06/10/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/28/2024 10:30:00 AM
- Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/30/2024 10:00:00 AM
- Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 • GlobeNewswire Inc. • 04/11/2024 10:00:00 AM
- Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/08/2024 10:00:00 AM
- Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors • GlobeNewswire Inc. • 03/28/2024 10:00:00 AM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM